2020
DOI: 10.21203/rs.3.rs-26384/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Regulation of degenerative spheroids after injury

Abstract: Background Neuronal injury leads to rapid, programmed disintegration of axons distal to the site of lesion. Much like other forms of axon degeneration ( e.g. developmental pruning, toxic insult from neurodegenerative disorder), Wallerian degeneration associated with injury is preceded by spheroid formation along axons. The mechanisms by which injury leads to formation of spheroids remains elusive. Methods Here, using wild-type and mutant neonatal mouse primary sympathetic neurons, immunostaining and calcium… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 59 publications
(93 reference statements)
0
1
0
Order By: Relevance
“…41 NAD + suppresses this process, whereas SARM1 mediates postspheroid rupture events that lead to axon disassembly. 56 There are alterations of NAD + metabolism in induced pluripotent stem cell–derived dopaminergic neurons with PD-associated GBA (α-glucocerebrosidase) mutations 57 ; there are also higher levels of SARM1 in PD neurons with mutations in parkin . 58 However, blocking programmed axon death by SARM1 depletion does not protect against neurodegeneration in all PD models, 59 suggesting some are not SARM1-dependent or there is pathway redundancy.…”
Section: Clinical Correlationsmentioning
confidence: 99%
“…41 NAD + suppresses this process, whereas SARM1 mediates postspheroid rupture events that lead to axon disassembly. 56 There are alterations of NAD + metabolism in induced pluripotent stem cell–derived dopaminergic neurons with PD-associated GBA (α-glucocerebrosidase) mutations 57 ; there are also higher levels of SARM1 in PD neurons with mutations in parkin . 58 However, blocking programmed axon death by SARM1 depletion does not protect against neurodegeneration in all PD models, 59 suggesting some are not SARM1-dependent or there is pathway redundancy.…”
Section: Clinical Correlationsmentioning
confidence: 99%